Skip to content

Vitamin D Supplementation Prevents Elderly Pneumonia

Vitamin D Supplementation Prevents Pneumonia in Institutionalized Elderly Subjects

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00877422
Enrollment
100
Registered
2009-04-07
Start date
2008-08-31
Completion date
Unknown
Last updated
2009-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Pneumonia

Keywords

vitamin deficiency

Brief summary

Pneumonia is the fourth leading cause of death and frequently occurs in institutionalized elderly people in Japan. Recently, several clinical and experimental studies have reported the importance of vitamin D in the regulation of immune functions and its deficiency is associated with susceptibility to some infections. In the present study, the investigators hypothesize that deficiency of serum vitamin D is associated with development of pneumonia, and supplementation of vitamin D may lower the incidence of pneumonia and prolong survival in institutionalized elderly subjects.

Interventions

DIETARY_SUPPLEMENTVitamin D3

Group A and Group C are followed without drugs and Group B is followed with vitamin D3.

Sponsors

Tohoku University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects are more than 65 years old and were resident in the facility for at least 6 months. * Subjects have no conditions known to interfere with vitamin D metabolism.

Exclusion criteria

* Subjects are excluded if they have: * renal failure * hepatic failure * hyper- or hypo-parathyroidism * HIV infection, or malignant diseases * Subjects are also excluded if they are taking corticosteroid, thiazide diuretics, or supplementary vitamins.

Design outcomes

Primary

MeasureTime frame
prevalence of pneumoniaone year

Secondary

MeasureTime frame
all cause mortalityone year

Countries

Japan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026